Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


FORM 10-Q

 

x    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF   
   THE SECURITIES EXCHANGE ACT OF 1934   

For the quarterly period ended July 27, 2007                                                                                          

OR

 

¨    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF   
   THE SECURITIES EXCHANGE ACT OF 1934   

For the transition period from                                                         to                                                        

Commission file number   1-6357

 

               ESTERLINE TECHNOLOGIES CORPORATION               
   (Exact name of registrant as specified in its charter)   

 

                    Delaware                     

(State or other Jurisdiction

of incorporation or organization)

    

                13-2595091                

(I.R.S. Employer

Identification No.)

500 108th Avenue N.E., Bellevue, Washington 98004

(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code 425/453-9400

Indicate by check mark whether the registrant:  (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes               X                                    No                           

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer    x            Accelerated filer    ¨            Non-accelerated filer    ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes                                                       No              X        

As of August 30, 2007, 25,805,269 shares of the issuer’s common stock were outstanding.


PART 1 – FINANCIAL INFORMATION

Item 1.           Financial Statements

ESTERLINE TECHNOLOGIES CORPORATION

CONSOLIDATED BALANCE SHEET

As of July 27, 2007 and October 27, 2006

(In thousands, except share amounts)

 

 

 

     July 27,
2007
  October 27,
2006

ASSETS

     (Unaudited)      

Current Assets

    

Cash and cash equivalents

   $ 83,682   $ 42,638

Cash in escrow

         4,409

Accounts receivable, net of allowances
    of $5,349 and $4,338

     223,157     191,737

Inventories

    

Raw materials and purchased parts

     110,664     89,480

Work in process

     97,270     66,333

Finished goods

     43,678     30,033
            
     251,612     185,846

Income tax refundable

     15,601     6,231

Deferred income tax benefits

     36,893     27,932

Prepaid expenses

     14,056     9,545
            

Total Current Assets

     625,001     468,338

Property, Plant and Equipment

     407,144     339,391

Accumulated depreciation

     192,594     168,949
            
     214,550     170,442

Other Non-Current Assets

    

Goodwill

     604,230     366,155

Intangibles, net

     371,080     241,657

Debt issuance costs, net of accumulated
    amortization of $4,219 and $3,204

     10,691     5,297

Deferred income tax benefits

     16,547     14,790

Other assets

     31,372     23,772
            
   $ 1,873,471   $   1,290,451
            

 

1


ESTERLINE TECHNOLOGIES CORPORATION

CONSOLIDATED BALANCE SHEET

As of July 27, 2007 and October 27, 2006

(In thousands, except share amounts)

 

 

 

     July 27,
2007
  October 27,
2006

LIABILITIES AND SHAREHOLDERS’ EQUITY

     (Unaudited)  

Current Liabilities

    

Accounts payable

   $ 83,468   $ 62,693

Accrued liabilities

     164,571     121,419

Credit facilities

     28,622     8,075

Current maturities of long-term debt

     10,245     5,538

Federal and foreign income taxes

     7,973     2,874
            

Total Current Liabilities

     294,879     200,599

Long-Term Liabilities

    

Long-term debt, net of current maturities

     555,385     282,307

Deferred income taxes

     120,991     72,349

Other liabilities

     42,956     23,629

Commitments and Contingencies

        

Minority Interest

     2,932     3,578

Shareholders’ Equity

    

Common stock, par value $.20 per share,
    authorized 60,000,000 shares, issued and
    outstanding 25,797,419 and 25,489,651 shares

     5,159     5,098

Additional paid-in capital

     284,242     270,074

Retained earnings

     472,381     400,985

Accumulated other comprehensive income

     94,546     31,832
            

Total Shareholders’ Equity

     856,328     707,989
            
   $ 1,873,471   $ 1,290,451
            

 

2


ESTERLINE TECHNOLOGIES CORPORATION

CONSOLIDATED STATEMENT OF OPERATIONS

For the Three and Nine Month Periods Ended July 27, 2007 and July 28, 2006

(Unaudited)

(In thousands, except per share amounts)

 

     Three Months Ended     Nine Months Ended  
     July 27,
2007
    July 28,
2006
    July 27,
2007
    July 28,
2006
 

Net Sales

   $       326,376     $       248,398     $       895,900     $       702,002  

Cost of Sales

     226,734       173,041       622,827       483,047  
                                
     99,642       75,357       273,073       218,955  

Expenses

        

Selling, general & administrative

     55,461       41,560       148,237       118,423  

Research, development &
engineering

     16,952       14,480       49,585       37,752  
                                

Total Expenses

     72,413       56,040       197,822       156,175  

Other

        

Other (income) expense

     7       17       24       (445 )

Insurance recovery

     (32,857 )           (37,314 )      
                                

Total Other

     (32,850 )     17       (37,290 )     (445 )
                                

Operating Earnings

     60,079       19,300       112,541       63,225  

Interest income

     (821 )     (393 )     (2,110 )     (2,250 )

Interest expense

     10,790       5,586       25,042       15,881  

Loss on extinguishment of debt

                       2,156  
                                

Other Expense, Net

     9,969       5,193       22,932       15,787  
                                

Income Before Income Taxes

     50,110       14,107       89,609       47,438  

Income Tax Expense

     11,217       2,576       18,096       9,439  
                                

Income Before Minority Interest

     38,893       11,531       71,513       37,999  

Minority Interest

     (58 )     (308 )     (117 )     (753 )
                                

Net Earnings

   $ 38,835     $ 11,223     $ 71,396     $ 37,246  
                                

Earnings Per Share:

        

Basic

   $ 1.51     $ .44     $ 2.79     $ 1.47  

Diluted

   $ 1.49     $ .43     $ 2.74     $ 1.44  

 

3


ESTERLINE TECHNOLOGIES CORPORATION

CONSOLIDATED STATEMENT OF CASH FLOWS

For the Nine Month Periods Ended July 27, 2007 and July 28, 2006

(Unaudited)

(In thousands)

 

     Nine Months Ended  
     July 27,
2007
    July 28,
2006
 

Cash Flows Provided (Used) by Operating Activities

    

Net earnings

   $ 71,396     $ 37,246  

Minority interest

     117       753  

Depreciation and amortization

     39,539       30,946  

Deferred income taxes

     (7,728 )     (4 )

Stock-based compensation

     5,105       4,226  

Gain on sale of short-term investments

           (610 )

Working capital changes, net of effect of acquisitions

        Accounts receivable

     22,620       5,466  

Inventories

     (13,583 )     (37,311 )

Prepaid expenses

     (2,172 )     183  

Accounts payable

     3,713       9,875  

Accrued liabilities

     (9,253 )     (11,142 )

Federal and foreign income taxes

     6,856       (11,381 )

Other liabilities

     (1,625 )     1,234  

Other, net

     (4,208 )     (617 )
                
     110,777       28,864  

Cash Flows Provided (Used) by Investing Activities

    

Purchases of capital assets

     (24,334 )     (20,399 )

Proceeds from sale of capital assets

     3,224       1,204  

Proceeds from sale of short-term investments

           63,266  

Acquisitions of businesses, net of cash acquired

     (344,313 )     (189,891 )
                
     (365,423 )     (145,820 )

 

4


ESTERLINE TECHNOLOGIES CORPORATION

CONSOLIDATED STATEMENT OF CASH FLOWS

For the Nine Month Periods Ended July 27, 2007 and July 28, 2006

(Unaudited)

(In thousands)

 

     Nine Months Ended  
     July 27,
2007
    July 28,
2006
 

Cash Flows Provided (Used) by Financing Activities

    

Proceeds provided by stock issuance under
    employee stock plans

   $ 7,557     $ 3,851  

Excess tax benefits from stock option exercises

     1,567       487  

Debt and other issuance costs

     (6,409 )      

Dividends paid to minority interest

     (763 )      

Net change in credit facilities

     20,322       2,900  

Proceeds from issuance of long-term debt

     275,000       100,000  

Repayment of long-term obligations

     (3,755 )     (70,907 )
                
     293,519       36,331  

Effect of Foreign Exchange Rates on Cash

     2,171       963  
                

Net Increase (Decrease) in Cash and Cash Equivalents

     41,044       (79,662 )

Cash and Cash Equivalents – Beginning of Period

     42,638       118,304  
                

Cash and Cash Equivalents – End of Period

   $         83,682     $         38,642  
                

Supplemental Cash Flow Information

    

Cash Paid for Interest

   $ 21,778     $ 19,838  

Cash Paid for Taxes

     11,974       14,575  

 

5


ESTERLINE TECHNOLOGIES CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Three and Nine Month Periods Ended July 27, 2007 and July 28, 2006

 

1. The consolidated balance sheet as of July 27, 2007, the consolidated statement of operations for the three and nine month periods ended July 27, 2007 and July 28, 2006, and the consolidated statement of cash flows for the nine month periods ended July 27, 2007 and July 28, 2006 are unaudited, but in the opinion of management, all of the necessary adjustments, consisting of normal recurring accruals, have been made to present fairly the financial statements referred to above in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, the above statements do not include all of the footnotes required for complete financial statements. The results of operations and cash flows for the interim periods presented are not necessarily indicative of results that can be expected for the full year.

 

2. The notes to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended October 27, 2006 provide a summary of significant accounting policies and additional financial information that should be read in conjunction with this Form 10-Q.

 

3. The timing of the Company’s revenues is impacted by the purchasing patterns of customers and, as a result, revenues are not generated evenly throughout the year. Moreover, the Company’s first fiscal quarter, November through January, includes significant holiday vacation periods in both Europe and North America.

 

4. Basic earnings per share is computed on the basis of the weighted average number of shares outstanding during the period. Diluted earnings per share includes the dilutive effect of stock options. Common shares issuable from stock options that are excluded from the calculation of diluted earnings per share because they were anti-dilutive, were 384,800 and 345,152 in the third fiscal quarter of 2007 and 2006, respectively. The weighted average number of shares outstanding used to compute basic earnings per share was 25,691,000 and 25,448,000 for the three month periods ended July 27, 2007 and July 28, 2006, respectively. The weighted average number of shares outstanding used to compute diluted earnings per share was 26,139,000 and 25,867,000 for the three month periods ended July 27, 2007 and July 28, 2006, respectively. The weighted average number of shares outstanding used to compute basic earnings per share was 25,604,000 and 25,390,000 for the nine month periods ended July 27, 2007, and July 28, 2006, respectively. The weighted average number of shares outstanding used to compute diluted earnings per share was 26,022,000 and 25,809,000 for the nine month periods ended July 27, 2007 and July 28, 2006, respectively.

 

6


5. Recent Accounting Pronouncements

In February 2007, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities,” (Statement No. 159). Statement No. 159 permits entities to choose to measure many financial instruments and certain other items at fair value that are not currently required to be measured at fair value. Statement No. 159 also establishes presentation and disclosure requirements designed to facilitate comparisons between entities that choose different measurement attributes for similar types of assets and liabilities. Statement No. 159 is effective for the Company’s fiscal year ended October 30, 2009. The Company is currently evaluating the impact of Statement No. 159 on the Company’s consolidated financial statements.

In October 2006, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans, an amendment of FASB Statement Nos. 87, 88, 106 and 123(R).” Statement No. 158 requires an entity to:

 

   

Recognize in its statements of financial position an asset for a defined benefit postretirement plan’s overfunded status or a liability for a plan’s underfunded status.

 

   

Measure a defined benefit postretirement plan’s assets and obligations that determine its funded status as of the end of the employer’s fiscal year.

 

   

Recognize changes in the funded status of a defined benefit postretirement plan in comprehensive income in the year in which the changes occur.

Statement No. 158 does not change the amount of net periodic benefit cost included in net income or address the various measurement issues associated with postretirement benefit plan accounting. The requirement to recognize the funded status of a defined benefit postretirement plan and the disclosure requirements are effective for the Company on October 26, 2007. If the Company had implemented Statement No. 158 as of October 27, 2006, the effect on the balance sheet would be an increase in pension liabilities and a decrease in accumulated other comprehensive income of approximately $8.5 million.

In September 2006, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 157, “Fair Value Measurements.” Statement No. 157 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. Statement No. 157 applies under other accounting pronouncements that require or permit fair value measurements. Statement No. 157 indicates, among other things, that a fair value measurement assumes the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability. Statement No. 157 is effective for the

 

7


Company’s year ending October 30, 2009. The Company is currently evaluating the impact of Statement No. 157 on the Company’s financial statements.

In June 2006, the Financial Accounting Standards Board issued FIN No. 48, “Accounting for Uncertainty in Income Taxes – an interpretation of FASB Statement No. 109,” which clarifies the accounting for uncertainty in income taxes recognized in an enterprises’ financial statements in accordance with FASB Statement No. 109, “Accounting for Income Taxes.” The interpretation prescribes a recognition method and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. FIN No. 48 requires recognition of tax benefits that satisfy a greater than 50% probability threshold. FIN No. 48 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. FIN No. 48 is effective for the Company beginning October 27, 2007. Management is assessing the potential impact that the adoption of FIN No. 48 will have on the Company’s consolidated financial statements.

 

6. The Company’s comprehensive income is as follows:

 

(In thousands)    Three Months Ended    Nine Months Ended  
     July 27,
2007
   July 28,
2006
   July 27,
2007
   July 28,
2006
 

Net Earnings

   $ 38,835    $ 11,223    $ 71,396    $ 37,246  

Change in Fair Value of Derivative
    Financial Instruments, Net of Tax

     16      105      1,722      1,491  

Minimum Pension Liability,
    Net of Tax

                    (3,682 )

Foreign Currency Translation Adj.

     21,152      6,172      60,992      18,056  
                             

Comprehensive Income

   $         60,003    $         17,500    $         134,110    $         53,111  
                             

 

7. On March 14, 2007, the Company acquired all of the outstanding capital stock of CMC Electronics Inc. (CMC), a leading aerospace/defense avionics company, for approximately $344.3 million in cash, including acquisition costs and an adjustment based on the amount of cash and net working capital as of closing. The acquisition significantly expands the scale of Esterline’s existing Avionics & Controls business. CMC Electronics is included in the Avionics & Controls segment and the results of its operations were included from the effective date of the acquisition.

The following summarizes the estimated fair market value of the assets acquired and liabilities assumed at the date of acquisition. The allocation of the purchase price was based upon a preliminary independent valuation report. The Company has not finalized the allocation of the purchase price to tangible and intangible assets and acquired net operating losses, unused tax credits and tax basis of acquired assets and liabilities. The amount allocated to goodwill is not expected to be deductible for income tax purposes.

 

8


(In thousands)

As of March 14, 2007

 

Current assets

   $             98,380

Property, plant and equipment

     39,136

Intangible assets subject to amortization

  

Programs (17 year weighted average useful life)

     119,509

Goodwill

     207,012
      

Total assets acquired

     464,037

Current liabilities assumed

     61,091

Deferred tax liabilities

     40,170

Pension and other liabilities

     18,481
      

Net assets acquired

   $ 344,295
      

Pro Forma Financial Information

The following pro forma financial information shows the results of operations for the three months ended July 28, 2006, and nine months ended July 27, 2007 and July 28, 2006, as though the acquisition of CMC had occurred at the beginning of each respective fiscal year. The pro forma financial information includes, where applicable, adjustments for: (i) the amortization of acquired intangible assets, (ii) additional interest expense on acquisition related borrowings and (iii) the income tax effect on the pro forma adjustments using a statutory tax rate of 32.0%. The pro forma adjustments related to the acquisition of CMC are based on a preliminary purchase price allocation. Differences between the preliminary and final purchase price allocation could have an impact on the pro forma financial information presented and such impact could be material. The pro forma financial information below is presented for illustrative purposes only and is not necessarily indicative of the operating results that would have been achieved had the acquisition been completed as of the date indicated above or the results that may be obtained in the future.

 

9


(In thousands)

           Three Months Ended                      Nine Months Ended          
    

July 28,

2006

     July 27,
2007
   July 28,
2006

Pro forma net sales

   $      291,655      $     967,598    $     846,756

Pro forma net income

   $        10,212      $ 70,439    $ 35,054

Basic earnings per share
as reported

   $              .44      $ 2.79    $ 1.47

Pro forma basic earnings
per share

   $              .40      $ 2.75    $ 1.38

Diluted earnings per share
as reported

   $              .43      $ 2.74    $ 1.44

Pro forma diluted earnings
per share

   $              .39      $ 2.71    $ 1.36

 

8. The Company acquired Wallop Defence Systems Limited (Wallop) and FR Countermeasures from Cobham plc on March 24, 2006 and December 23, 2005, respectively. Wallop and FR Countermeasures, manufacturers of military pyrotechnic countermeasure devices, strengthen the Company’s international and U. S. position in countermeasure devices. The Company paid $65.0 million for both companies, including acquisition costs and an adjustment based on the amount of indebtedness and net working capital as of closing. The Company assumed a $4.2 million obligation at FR Countermeasures. In addition, the Company may pay an additional purchase price up to U.K. £10.0 million, or approximately $20.0 million, depending on the achievement of certain objectives. At the time of the acquisition of Wallop, the Company and the seller agreed that some environmental remedial activities may need to be carried out, and these activities are currently on-going. Under the terms of the Stock Purchase Agreement, a portion of the costs of any environmental remedial activities will be reimbursed by the seller if the cost is incurred within five years of the consummation of the acquisition. Wallop and FR Countermeasures are included in the Advanced Materials segment.

The following summarizes the estimated fair market value of the assets acquired and liabilities assumed at the date of acquisition. The allocation of the purchase price was based upon an independent valuation report. The amount allocated to goodwill is not currently deductible for income tax purposes.

 

10


(In thousands)

As of March 24, 2006 (Wallop) and December 23, 2005 (FR Countermeasures)

 

Current assets

   $         11,479

Property, plant and equipment

     20,963

Intangible assets subject to amortization
    Programs (17 year weighted average useful life)

     21,793

Goodwill

     28,948

Deferred income tax benefit

     2,151
      

Total assets acquired

     85,334

Debt assumed

     4,212

Current liabilities assumed

     9,180

Deferred tax liabilities

     6,909
      

Net assets acquired

   $ 65,033
      

On June 26, 2006, an explosion occurred at Wallop, which resulted in one fatality and several minor injuries. The incident destroyed an oven complex for the production of advanced flares and significantly damaged the South facility. Although the South facility is expected to be closed for more than two years due to the requirements of the Health Safety Executive (HSE) to review the cause of the accident, normal operations are continuing at unaffected portions of the facility. The HSE investigation will not be completed until a Coroner’s Inquest is filed, possibly in 2008. Although it is not possible to determine the results of the HSE investigation or how the Coroner will rule, management does not expect to be found in breach of the Health & Safety Act related to the accident and, accordingly, no amounts have been recorded for any potential fines that may be assessed by the HSE. The HSE will also review and approve the plans for repairing or rebuilding the damaged facility.

The operation is insured under a property, casualty and business interruption insurance policy and in June 2007, the Company settled its insurance claim for £24.0 million, including payments already received. During the third quarter of fiscal 2007, the Company recorded insurance recoveries of $32.9 million, net of the write-off of the damaged facility. Insurance recoveries totaled $37.3 million, net of the write-off of the damaged facility, in the first nine months of fiscal 2007.

 

9. On December 16, 2005, the Company acquired all of the outstanding capital stock of Darchem Holdings Limited (Darchem), a manufacturer of thermally engineered components for critical aerospace applications for U.K. £68.7 million in cash (approximately $121.7 million including acquisition costs and an adjustment based on the amount of cash and net working capital of Darchem as of closing). Darchem holds a leading position in its niche market and fits the Company’s engineered-to-order model. Darchem is included in the Advanced Materials segment and the results of its operations were included from the effective date of the acquisition.

 

11


The following summarizes the estimated fair market value of the assets acquired and liabilities assumed at the date of acquisition. The allocation of the purchase price was based upon an independent valuation report. The amount allocated to goodwill is not currently deductible for income tax purposes.

(In thousands)

As of December 16, 2005

 

Current assets

   $         21,864

Property, plant and equipment

     8,499

Intangible assets subject to amortization

  

Programs (18 year weighted average useful life)

     46,441

Customer relationships (6 year weighted average useful life)

     2,215

Patents (11 year weighted average useful life)

     3,083

Other (1 year useful life)

     284
      
     52,023

Trade name

     6,219

Other

     171

Goodwill

     60,313
      

Total assets acquired

     149,089

Current liabilities assumed

     8,499

Deferred tax liabilities

     18,933
      

Net assets acquired

   $ 121,657
      

 

10.

The effective income tax rate for the first nine months of fiscal 2007 was 23.1% (before a $2.6 million tax benefit), compared with 29.5% (before a $4.5 million reduction of previously estimated tax liabilities) for the first nine months of fiscal 2006. The $2.6 million tax benefit in the first nine months of 2007 was the result of the following: 1) a $1.8 million benefit from the retroactive extension of the U.S. Research and Experimentation tax credit that was signed into law on December 21, 2006; 2) a $1.4 million reduction in U.K. subsidiaries’ deferred income taxes resulting from the enactment of a tax law reducing U.K. statutory corporate income tax from 30% to 28%; and 3) a $0.6 million increase of previously estimated tax liabilities due to a reconciliation of prior years’ income tax returns to the provision for income tax. The change in the effective tax rate for the first nine months of fiscal 2007 compared to the prior-year period reflects the incremental financing costs attributable to CMC’s acquisition in income before income taxes and the effect of including CMC’s tax credits and other tax efficiencies. In addition, for the first nine months of fiscal 2007, the effective tax rate was favorably affected by the extension of the U.S. Research and Experimentation tax credit through December 31, 2007. In the first nine months of fiscal 2006, the $4.5 million reduction of previously estimated tax liabilities was the result of a $1.6 million reduction of previously estimated tax liabilities due to the expiration of the statute of limitations and adjustments resulting from a reconciliation of the prior year’s income tax return to the provision for income tax and $2.9 million for favorable settlements

 

12


 

of tax audits. The effective tax rate differed from the statutory rate in the first nine months of fiscal 2007 and 2006, as both years benefited from various tax credits and certain foreign interest expense deductions.

 

11. As of July 27, 2007, the Company has two share-based compensation plans, which are described below. The compensation cost that has been charged against income for those plans for the first nine months of fiscal 2007 and 2006 was $5.1 million and $4.2 million, respectively. The total income tax benefit recognized in the income statement for share-based compensation arrangements for the first nine months of fiscal 2007 and 2006 was $1.6 million and $1.1 million, respectively.

In March 2002, the Company’s shareholders approved the establishment of an Employee Stock Purchase Plan (ESPP) under which 300,000 shares of the Company’s common stock are reserved for issuance to employees. On March 1, 2006, the Company’s shareholders authorized an additional 150,000 shares of the Company’s stock under the ESPP. The plan qualifies as a noncompensatory employee stock purchase plan under Section 423 of the Internal Revenue Code. Employees are eligible to participate through payroll deduction subject to certain limitations.

At the end of each offering period, usually six months, shares are purchased by the participants at 85% of the lower of the fair market value on the first day of the offering period or the purchase date. During the first nine months of fiscal 2007, employees purchased 79,404 shares at an average fair market value price of $40.13 per share, leaving a balance of 122,891 shares available for issuance in the future. As of July 27, 2007, deductions aggregating $358,471 were accrued for the purchase of shares on December 15, 2007.

The fair value of the awards under the employee stock purchase plan was estimated using a Black-Scholes pricing model which uses the assumptions noted in the following table. The Company uses historical data to estimate volatility of the Company’s common stock. The risk-free rate for the contractual life of the option is based on the U.S. Treasury zero coupon issues in effect at the time of grant.

 

             Nine Months Ended        
     July 27,
2007
   July 28,
2006

Risk-free interest rate (U.S. Treasury zero coupon issues)

   5.15%    3.20 – 4.20%

Expected dividend yield

   —        —    

Expected volatility

   21.4 – 39.9%    30.0 – 30.7%

Expected life (months)

   6        6    

The Company also has an equity incentive plan for officers and key employees. On March 1, 2006, the Company’s shareholders authorized the issuance of an additional 1,000,000 shares of the Company’s common stock under the equity incentive plan. At July 27, 2007, the Company had 2,370,850 shares reserved for issuance to officers and key employees, of which 722,900 shares were available to be granted in the future.

 

13


The Board of Directors authorized the Compensation Committee to administer awards granted under the equity incentive plan, including option grants, and to establish the terms of such awards. Awards under the equity incentive plan may be granted to eligible employees of the Company over the 10-year period ending March 3, 2014. Options granted become exercisable ratably over a period of four years following the date of grant and expire on the tenth anniversary of the grant. Option exercise prices are equal to the fair market value of the Company’s common stock on the date of grant. The weighted-average grant date fair value of options granted during the nine month periods ended July 27, 2007 and July 28, 2006, was $21.55 per share and $22.14 per share, respectively.

The fair value of each option granted by the Company was estimated using a Black-Scholes pricing model which uses the assumptions noted in the following table. The Company uses historical data to estimate volatility of the Company’s common stock and option exercise and employee termination assumptions. The range of the expected term reflects the results from certain groups of employees exhibiting different behavior. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury zero coupon issues in effect at the time of the grant.

 

                 Nine Months Ended            
     July 27,
2007
     July 28,
2006

Risk-free interest rate (U.S. Treasury zero coupon issues)

   4.31 – 4.82%      4.53 – 5.18%

Expected dividend yield

   —          —    

Expected volatility

   43.3 – 44.3%      45.0%

Expected term (years)

         4.5 – 9.5            6.5 – 9.5

The following table summarizes the changes in outstanding options granted under the Company’s stock option plans for the nine month period ended July 27, 2007:

 

              Weighted Average    
    Shares
    Subject to    
Option
    Remaining
Contractual
    Term (years)    
  Exercise
Price

Outstanding, beginning of period

  1,469,000       $ 25.80

Granted

  410,000         40.03

Exercised

  (216,100 )       20.21

Canceled or expired

  (14,950 )       35.33
             

Outstanding, end of period

  1,647,950     6.83   $ 30.02
               

Exercisable, end of period

  872,400     5.23   $     23.32
               

 

14


The aggregate intrinsic value of option shares outstanding and exercisable at July 27, 2007 was $26.6 million and $19.9 million, respectively.

The number of option shares vested or that are expected to vest at July 27, 2007 was 1.6 million and the aggregate intrinsic value was $26.4 million. The weighted average exercise price and weighted average remaining contractual term of option shares vested or that are expected to vest at July 27, 2007 was $30.00 and 6.79 years, respectively.

The table below presents stock activity related to stock options exercised in the periods ended July 27, 2007 and July 28, 2006:

 

(In thousands)                Nine Months Ended            
     July 27,
2007
   July 28,
2006

Proceeds from stock options exercised

   $     4,366    $     1,309

Tax benefits related to stock options exercised

     1,567      736

Intrinsic value of stock options exercised

     3,272      1,992

Total unrecognized compensation expense for options that have not vested as of July 27, 2007, is $8.4 million, which will be recognized over a weighted average period of 1.56 years. The total fair value of option shares vested during the period ended July 27, 2007 was $3.4 million.

The following table summarizes information for stock options outstanding at July 27, 2007:

 

     Options Outstanding    Options Exercisable

        Range of
    Exercise Prices

     Shares      Weighted
Average
Remaining
Life (years)
   Weighted
Average
Price
   Shares    Weighted
Average
Price

$    11.38 –  18.95

   351,600    3.98    $     15.54    351,600    $     15.54

      18.96 –  26.24

   345,250    5.53      22.97    277,250      22.85

      26.25 –  38.90

   374,400    7.13      35.14    203,200      34.31

      38.91 –  38.91

   329,300    9.36      38.91        

      38.92 –  45.47

   247,400    8.85      40.85    40,350      39.04

 

15


12. The Company’s principal pension plans include a U.S. pension plan maintained by Esterline, non-U.S. plans maintained by CMC, and U.S. and non-U.S. plans maintained by Leach Holding Corporation. Components of net periodic pension cost consisted of the following:

 

(In thousands)        Three Months Ended             Nine Months Ended      
     July 27,
2007
   

  July 28,  

2006

      July 27,  
2007
      July 28,  
2006
 

Components of Net Periodic Pension Cost

        

Service cost

   $     1,669     $     1,085     $     3,944     $     2,845  

Interest cost

     3,890       2,522       9,826       7,510  

Adjustment

           1,091             1,091  

Expected return on plan assets

     (5,217 )     (3,176 )     (13,066 )     (9,535 )

Amortization of prior service cost

     5       5       14       14  

Amortization of actuarial loss

     69       452       163       1,264  
                                

Net Periodic Cost

   $ 416     $ 1,979     $ 881     $ 3,189  
                                

 

The Company’s principal postretirement plans include non-U.S. plans maintained by CMC, which are non-contributory healthcare and life insurance plans. The components of expense for these other retirement benefits consisted of the following:

 

   

(In thousands)        Three Months Ended             Nine Months Ended      
     July 27,
2007
      July 28,  
2006
      July 27,  
2007
      July 28,  
2006
 

Components of Net Periodic Pension Cost

        

Service cost

   $ 87     $     $ 127     $  

Interest cost

     142             208        
                                

Net Periodic Cost

   $ 229     $     $ 335     $  
                                

 

16


13. Segment information:

Business segment information for continuing operations includes the segments of Avionics & Controls, Sensors & Systems and Advanced Materials.

 

(In thousands)        Three Months Ended             Nine Months Ended      
     July 27,
2007
    July 28,
2006
    July 27,
2007
    July 28,
2006
 

Sales

        

Avionics & Controls

   $ 121,512     $ 71,191     $ 305,331     $ 205,497  

Sensors & Systems

     97,418       84,672       281,732       241,319  

Advanced Materials

     107,446       92,535       308,837       255,186  
                                

Total Sales

   $ 326,376     $ 248,398     $ 895,900     $ 702,002  
                                

Income from Operations

        

Avionics & Controls

   $ 9,874     $ 11,040     $ 33,159     $ 31,711  

Sensors & Systems

     11,044       5,333       25,018       18,416  

Advanced Materials

     48,524       9,853       80,520       33,669  
                                

Segment Earnings

     69,442       26,226       138,697       83,796  

Corporate expense

     (9,356 )     (6,909 )     (26,132 )     (21,016 )

Other income (expense)

     (7 )     (17 )     (24 )     445  

Interest income

     821       393       2,110       2,250  

Interest expense

     (10,790 )     (5,586 )     (25,042 )     (15,881 )

Loss on extinguishment of debt

                       (2,156 )
                                
   $ 50,110     $ 14,107     $ 89,609     $ 47,438  
                                

 

14.

On November 15, 2005, the $30.0 million 6.4% Senior Notes matured and were paid. Additionally, on November 15, 2005, the Company prepaid the outstanding principal amount of the $40.0 million 6.77% Senior Notes due November 15, 2008. Under the terms of the Note Purchase Agreement, the Company paid an additional $2.2 million make-whole payment, which was recorded as a loss on extinguishment of debt in the first fiscal quarter of 2006. On February 10, 2006, the Company amended its credit agreement to provide a $100.0 million term loan facility, which may be drawn in U.S. dollars, U.K. pounds or euros. In addition, the amendment provides that up to $25.0 million of the credit facility and up to $50.0 million of the letter of credit may be drawn in U.K. pounds or euros in addition to U.S. dollars. On February 10, 2006, the Company borrowed U.K. £57.0 million, or approximately $100.0 million, under the term loan facility. The Company used the proceeds from the loan as working capital for its U.K. operations and to repay a portion of its outstanding borrowings under the revolving credit facility. The principal amount of the loan is payable quarterly commencing on March 31, 2007 through the termination date of November 14, 2010, according to a payment schedule by which 1.25% of the principal amount is paid in each quarter of 2007, 2.50% in each quarter of 2008, 5.00% in each quarter of 2009 and 16.25% in each quarter of 2010. The loan accrues interest at a variable rate based on the British Bankers Association Interest Settlement Rate for deposits in U.K. pounds plus an additional margin

 

17


 

amount that ranges from 1.13% to 0.50% depending upon the Company’s leverage ratio. At July 27, 2007, the interest rate on the term loan was 6.81%. The Company entered into an interest rate swap agreement on the full principal amount by which the variable interest rate was exchanged for a fixed interest rate of 4.75% plus an additional margin amount determined by reference to the Company’s leverage ratio. In addition, in November 2005, the Company collateralized a $9.9 million letter of credit with an equivalent amount of cash and cash equivalents.

On March 1, 2007, the Company issued $175.0 million in 6.625% Senior Notes due March 1, 2017 and requiring semi-annual interest payments in March and September of each year until maturity. The net proceeds from this offering were used to pay a portion of the purchase price of the acquisition of CMC for approximately $344.3 million, including acquisition costs. The Senior Notes are general unsecured obligations of the Company. The Senior Notes are guaranteed, jointly and severally, by all the existing and future domestic subsidiaries of the Company unless designated as an “unrestricted subsidiary” under the indenture covering the Senior Notes. The Senior Notes are subject to redemption at the option of the Company, in whole or in part, on or after March 1, 2010 at redemption prices starting at 106.625% of the principal amount plus accrued interest during the period beginning March 1, 2007 and declining annually to 100% of principal and accrued interest on March 1, 2012.

On March 13, 2007, the Company amended its credit agreement to increase the existing revolving credit facility to $200.0 million and to provide an additional $100.0 million U.S. term loan facility. On March 13, 2007, Esterline borrowed $60.0 million under the revolving credit facility and $100.0 million under the U.S. term loan facility; the Company repaid $35.0 million through July 27, 2007. The Company used the proceeds to pay a portion of the purchase price of the acquisition of CMC. The principal amount of the U.S. term loan facility is payable quarterly commencing on June 30, 2008 through the termination date of March 13, 2012. According to the payment schedule, the first four payments equal to 1.25% of the initial principal amount, the following eight payments equal to 2.50% of the initial principal amount, the following three payments equal to 5.00% of the initial principal amount, with the final payment equal to 60% of the initial principal amount. The loan accrues interest at a variable rate based on the Eurodollar rate plus an additional margin amount that ranges from 0.625% to 1.250% depending upon the Company’s leverage ratio. As of July 27, 2007, the interest rate on the term loan was 6.30%.

 

15.

The following schedules set forth condensed consolidating financial information as required by Rule 3-10 of Securities and Exchange Commission Regulation S-X as of July 27, 2007, and October 27, 2006, and for the applicable periods ended July 27, 2007, and July 28, 2006, for (a) Esterline Technologies Corporation (the Parent); (b) on a combined basis, the subsidiary guarantors (Guarantor Subsidiaries) of the Senior Subordinated Notes which include Advanced Input Devices, Inc., Amtech Automated Manufacturing Technology, Angus Electronics Co., Armtec Countermeasures Co., Armtec Countermeasures TNO Co., Armtec Defense Products Co., AVISTA, Incorporated, BVR Technologies Co., CMC DataComm Inc., CMC Electronics Acton Inc., CMC Electronics Aurora Inc., EA

 

18


Technologies Corporation, Equipment Sales Co., Esterline Canadian Holding Co., Esterline Sensors Services Americas, Inc., Esterline Technologies Holdings Limited, Esterline Technologies Ltd. (England), H.A. Sales Co., Hauser Inc., Hytek Finishes Co., Janco Corporation, Kirkhill-TA Co., Korry Electronics Co., Leach Holding Corporation, Leach International Corporation, Leach International Mexico S. de R.L. de C.V. (Mexico), Leach Technology Group, Inc., Mason Electric Co., MC Tech Co., Memtron Technologies Co., Norwich Aero Products, Inc., Palomar Products, Inc., Pressure Systems, Inc., Pressure Systems International, Inc., Surftech Finishes Co., UMM Electronics Inc., and (c) on a combined basis, the subsidiary non-guarantors (Non-Guarantor Subsidiaries), which include Advanced Input Devices Ltd. (U.K.), Auxitrol S.A., Auxitrol Technologies S.A.S., BAE Systems Canada/Air TV LLC, Beacon Electronics Inc., CMC Electronics Holdings Inc., CMC Electronics Inc., Darchem Engineering Limited, Darchem Holdings Ltd., Darchem Insulation Systems Limited, Esterline Acquisition Ltd. (U.K.), Esterline Canadian Acquisition Company, Esterline Canadian Limited Partnership, Esterline Foreign Sales Corporation (U.S. Virgin Islands), Esterline Input Devices Asia Ltd. (Barbados), Esterline Input Devices Ltd. (Shanghai), Esterline Sensors Services Asia PTE, Ltd. (Singapore), Esterline Technologies Denmark ApS (Denmark), Guizhou Leach-Tianyi Aviation Electrical Company Ltd. (China), Leach International Asia-Pacific Ltd. (Hong Kong), Leach International Europe S.A. (France), Leach International Germany GmbH (Germany), Leach International U.K. (England), Leach Italia Srl. (Italy), LRE Medical GmbH (Germany), ML Wallop Defence Systems Ltd. (U.K.), Muirhead Aerospace Ltd., Norcroft Dynamics Ltd., Pressure Systems International Ltd., TA Mfg. Limited (U.K.), Wallop Defence Systems Limited, Weston Aero Ltd. (England), and Weston Aerospace Ltd. (England). Adjustments have been made to prior-year reported financial statements of the parent, guarantor, non-guarantor and eliminations to conform with the current year’s presentation due to certain reclassifications of guarantor and non-guarantor subsidiaries and to apply the equity method of accounting for certain guarantor subsidiaries. At October 27, 2006, total assets of guarantors increased $95.5 million, total liabilities increased $24.4 million, and total equity increased $71.1 million. Total assets of non-guarantors increased $10.8 million, total liabilities decreased by $110.1 million, and total equity increased $120.9 million. For the three month period ended July 28, 2006, net earnings of guarantors decreased $0.2 million. Net income of non-guarantors increased $1.2 million. For the nine month period ended July 28, 2006, net earnings of guarantors increased $1.3 million. Net income of non-guarantors increased $2.2 million. The guarantor subsidiaries are direct and indirect wholly-owned subsidiaries of Esterline Technologies and have fully and unconditionally, jointly and severally, guaranteed the Senior Subordinated Notes.

 

19


Condensed Consolidating Balance Sheet as of July 27, 2007.

(In thousands)

 

     Parent    Guarantor
Subsidiaries
   Non-
Guarantor
Subsidiaries
   Eliminations     Total

Assets

             

Current Assets

             

Cash and cash equivalents

   $ 11,997    $ 1,424    $ 70,261    $     $ 83,682

Cash in escrow

                         

Accounts receivable, net

     176      105,826      117,155            223,157

Inventories

          121,283      130,329            251,612

Income tax refundable

          6,737      8,864            15,601

Deferred income tax benefits

     28,909           7,984            36,893

Prepaid expenses

     104      4,445      9,507            14,056

Total Current Assets

     41,186      239,715      344,100            625,001

Property, Plant & Equipment, Net

     2,046      106,557      105,947            214,550

Goodwill

          196,993      407,237            604,230

Intangibles, Net

     73      71,217      299,790            371,080

Debt Issuance Costs, Net

     10,691                      10,691

Deferred Income Tax Benefits

     13,661           2,886            16,547

Other Assets

     4,706      16,087      10,579            31,372

Amounts Due (To) From Subsidiaries

     195,826                (195,826 )    

Investment in Subsidiaries

     1,237,784      192,766      26,169      (1,456,719 )    

Total Assets

   $ 1,505,973    $     823,335    $   1,196,708      $  (1,652,545 )   $ 1,873,471
 

 

20


(In thousands)

 

      Parent     Guarantor
Subsidiaries
   Non-
Guarantor
Subsidiaries
   Eliminations     Total

Liabilities and Shareholders’ Equity

            

Current Liabilities

            

Accounts payable

   $        5,097     $    19,738    $       58,633    $               —     $      83,468

Accrued liabilities

   31,812     48,509    84,250        164,571

Credit facilities

   25,000        3,622        28,622

Current maturities of
long-term debt

   8,659     1,130    456        10,245

Federal and foreign
income taxes

   (8,083 )   15,493    563        7,973

Total Current Liabilities

   62,485     84,870    147,524        294,879

Long-Term Debt, Net

   552,328     1,462    1,595        555,385

Deferred Income Taxes

   29,120        91,871        120,991

Other Liabilities

   5,712     10,203    27,041        42,956

Amounts Due To (From) Subsidiaries

       68,523    94,469    (162,992 )  

Minority Interest

          2,932        2,932

Shareholders’ Equity

   856,328     658,277    831,276    (1,489,553 )   856,328

Total Liabilities and Shareholders’ Equity

   $ 1,505,973     $  823,335    $  1,196,708    $ (1,652,545)     $  1,873,471
 

 

21


Condensed Consolidating Statement of Operations for the three month period ended July 27, 2007.

(In thousands)

 

      Parent     Guarantor
Subsidiaries
    Non-
Guarantor
Subsidiaries
    Eliminations     Total  

Net Sales

   $       —     $   189,826     $   140,228     $ (3,678 )   $   326,376  

Cost of Sales

           127,712       102,700       (3,678 )     226,734  
   
           62,114       37,528             99,642  

Expenses

          

Selling, general and
administrative

           24,915       30,546             55,461  

Research, development
and engineering

           6,771       10,181             16,952  
   

Total Expenses

           31,686       40,727             72,413  
Other           

Other (income) expense

           (1 )     8             7  

Insurance recovery

                 (32,857 )           (32,857 )
   

Total Other

           (1 )     (32,849 )           (32,850 )
   

Operating Earnings

           30,429       29,650             60,079  

Interest income

     (4,758 )     (1,110 )     (8,863 )     13,910       (821 )

Interest expense

     10,568       8,259       5,873       (13,910 )     10,790  
   

Other Expense, Net

     5,810       7,149       (2,990 )           9,969  
   

Income (Loss) Before
Income Taxes

     (5,810 )     23,280       32,640             50,110  

Income Tax Expense (Benefit)

     (1,377 )     6,897       5,697             11,217  
   

Income (Loss) Before

          

Minority Interest

     (4,433 )     16,383       26,943             38,893  

Minority Interest

                 (58 )           (58 )
   

Income (Loss)

     (4,433 )     16,383       26,885             38,835  

Equity in Net Income of
Consolidated Subsidiaries

     43,268       4,269       (668 )     (46,869 )      
   

Net Income (Loss)

   $     38,835     $     20,652     $     26,217     $   (46,869 )   $     38,835  
   

 

22


Condensed Consolidating Statement of Operations for the nine month period ended July 27, 2007.

(In thousands)

 

      Parent     Guarantor
Subsidiaries
    Non-
Guarantor
Subsidiaries
    Eliminations     Total  

Net Sales

   $           —     $  531,467     $  375,533     $    (11,100 )   $  895,900  

Cost of Sales

       361,966     271,961     (11,100 )   622,827  
   
       169,501     103,572         273,073  

Expenses

          

Selling, general
and administrative

       73,682     74,555         148,237  

Research, development
and engineering

       19,947     29,638         49,585  
   

Total Expenses

       93,629     104,193         197,822  
Other           

Other expense

           24         24  

Insurance recovery

           (37,314 )       (37,314 )
   

Total Other

           (37,290 )       (37,290 )
   

Operating Earnings

       75,872     36,669         112,541  

Interest income

   (15,472 )   (3,789 )   (12,878 )   30,029     (2,110 )

Interest expense

   24,376     16,069     14,626     (30,029 )   25,042  
   

Other Expense, Net

   8,904     12,280     1,748         22,932  
   

Income (Loss) Before
Income Taxes

   (8,904 )   63,592     34,921         89,609  

Income Tax Expense (Benefit)

   (2,060 )   14,283     5,873         18,096  
   

Income (Loss) Before
Minority Interest

   (6,844 )   49,309     29,048         71,513  

Minority Interest

           (117 )       (117 )
   

Income (Loss)

   (6,844 )   49,309     28,931         71,396  

Equity in Net Income of
Consolidated Subsidiaries

   78,240     6,480     (668 )   (84,052 )    
   

Net Income (Loss)

   $    71,396     $    55,789     $    28,263     $    (84,052 )   $    71,396  
   

 

23


Condensed Consolidating Statement of Cash Flows for the nine month period ended July 27, 2007.

(In thousands)

 

      Parent     Guarantor
Subsidiaries
    Non-
Guarantor
Subsidiaries
    Eliminations     Total  

Cash Flows Provided (Used)
by Operating Activities

          

Net earnings (loss)

   $    71,396     $    55,789     $      28,263     $    (84,052 )   $    71,396  

Minority interest

           117         117  

Depreciation & amortization

       19,247     20,292         39,539  

Deferred income taxes

   (992 )   25     (6,761 )       (7,728 )

Stock-based compensation

       2,881     2,224         5,105  

Working capital changes, net of
effect of acquisitions

          

Accounts receivable

   125     173     22,322         22,620  

Inventories

       (6,999 )   (6,584 )       (13,583 )

Prepaid expenses

   60     266     (2,498 )       (2,172 )

Accounts payable

   4,372     (1,701 )   1,042         3,713  

Accrued liabilities

   4,693     (9,746 )   (4,200 )       (9,253 )

Federal & foreign income taxes

   (10,874 )   12,499     5,231         6,856  

Other liabilities

   (659 )   205     (1,171 )       (1,625 )

Other, net

   61     (1,794 )   (2,475 )       (4,208 )
   
   68,182     70,845     55,802     (84,052 )   110,777  

Cash Flows Provided (Used)
by Investing Activities

          

Purchases of capital assets

   (118 )   (11,912 )   (12,304 )       (24,334 )

Proceeds from sale of capital assets

       757     2,467         3,224  

Acquisitions of businesses, net

           (344,313 )       (344,313 )
   
   (118 )   (11,155 )   (354,150 )       (365,423 )

 

24


(In thousands)

 

      Parent     Guarantor
Subsidiaries
    Non-
Guarantor
Subsidiaries
    Eliminations    Total  

Cash Flows Provided (Used)
by Financing Activities

           

Proceeds provided by stock
issuance under employee
stock plans

   7,557                7,557  

Excess tax benefits from
stock option exercises

   1,567                1,567  

Debt and other issuance costs

   (6,409 )              (6,409 )

Dividends paid to minority interest

           (763 )      (763 )

Net change in credit facilities

   20,000         322        20,322  

Proceeds from issuance of
long-term debt

   275,000                275,000  

Repayment of long-term debt

   (2,832 )   (792 )   (131 )      (3,755 )

Net change in intercompany
financing

   (365,290 )   (60,197 )   341,435     84,052     
   
   (70,407 )   (60,989 )   340,863     84,052    293,519  

Effect of Foreign Exchange
Rates on Cash

   (3 )   51     2,123        2,171  
   

Net Increase (Decrease) in Cash
and Cash Equivalents

   (2,346 )   (1,248 )   44,638        41,044  

Cash and Cash Equivalents
– Beginning of Period

   14,343     2,672     25,623        42,638  
   

Cash and Cash Equivalents
– End of Period

   $     11,997     $      1,424     $     70,261     $        —    $     83,682  
   

 

25


Condensed Consolidating Balance Sheet as of October 27, 2006.

(In thousands)

 

     Parent    Guarantor
Subsidiaries
   Non-
Guarantor
Subsidiaries
   Eliminations     Total

Assets

             

Current Assets

             

Cash and cash equivalents

   $ 14,343    $ 2,672    $ 25,623    $     $ 42,638

Cash in escrow

     4,409                      4,409

Accounts receivable, net

     301      105,584      85,852            191,737

Inventories

          107,864      77,982            185,846

Income tax refundable

          3,394      2,837            6,231

Deferred income tax benefits

     25,227      5      2,700            27,932

Prepaid expenses

     164      4,480      4,901            9,545

Total Current Assets

     44,444      223,999      199,895            468,338

Property, Plant & Equipment, Net

     2,324      95,070      73,048            170,442

Goodwill

          195,474      170,681            366,155

Intangibles, Net

     73      75,928      165,656            241,657

Debt Issuance Costs, Net

     5,297                      5,297

Deferred Income Tax Benefits

     13,531           1,259            14,790

Other Assets

     2,708      15,344      5,720            23,772

Amounts Due To (From)

             

Subsidiaries

     168,889                (168,889 )    

Investment in Subsidiaries

     826,622      192,010           (1,018,632 )    

Total Assets

   $   1,063,888    $     797,825    $     616,259      $  (1,187,521 )   $   1,290,451
 

 

26


(In thousands)

 

      Parent    Guarantor
Subsidiaries
    Non-
Guarantor
Subsidiaries
   Eliminations     Total

Liabilities and Shareholders’ Equity

            

Current Liabilities

            

Accounts payable

   $            725    $    20,678     $    41,290    $                —     $       62,693

Accrued liabilities

   30,651    57,455     33,313        121,419

Credit facilities

   5,000        3,075        8,075

Current maturities of
long-term debt

   4,054        1,484        5,538

Federal and foreign
income taxes

   2,791    72     11        2,874

Total Current Liabilities

   43,221    78,205     79,173        200,599

Long-Term Debt, Net

   278,365        3,942        282,307

Deferred Income Taxes

   27,942    (20 )   44,427        72,349

Other Liabilities

   6,371    9,998     7,260        23,629

Amounts Due To (From) Subsidiaries

      28,228     187,381    (215,609 )  

Minority Interest

          3,578        3,578

Shareholders’ Equity

   707,989    681,414     290,498    (971,912 )   707,989

Total Liabilities and
Shareholders’ Equity

   $  1,063,888    $  797,825     $  616,259    $  (1,187,521)     $  1,290,451
 

 

27


Condensed Consolidating Statement of Operations for the three month period ended July 28, 2006.

(In thousands)

 

      Parent     Guarantor
Subsidiaries
    Non-
Guarantor
Subsidiaries
    Eliminations     Total  

Net Sales

   $          —     $  157,674     $    95,044     $    (4,320 )   $    248,398  

Cost of Sales

       109,054     68,307     (4,320 )   173,041  
   
       48,620     26,737         75,357  

Expenses

          

Selling, general
and administrative

       25,257     16,303         41,560  

Research, development
and engineering

       5,579     8,901         14,480  
   

Total Expenses

       30,836     25,204         56,040  

Other

          

Other (income) expense

       (493 )   510         17  
   

Total Other

       (493 )   510         17  
   

Operating Earnings

       18,277     1,023         19,300  

Interest income

   (6,768 )   (1,249 )   (421 )   8,045     (393 )

Interest expense

   5,373     4,198     4,060     (8,045 )   5,586  
   

Other Expense, Net

   (1,395 )   2,949     3,639         5,193  
   

Income (Loss) Before
Income Taxes

   1,395     15,328     (2,616 )       14,107  

Income Tax Expense (Benefit)

   381     3,030     (835 )       2,576  
   

Income (Loss) Before
Minority Interest

   1,014     12,298     (1,781 )       11,531  

Minority Interest

           (308 )       (308 )
   

Income (Loss)

   1,014     12,298     (2,089 )       11,223  

Equity in Net Income of
Consolidated Subsidiaries

   10,209     970         (11,179 )    
   

Net Income (Loss)

   $    11,223     $    13,268     $    (2,089 )   $  (11,179 )   $    11,223  
   

 

28


Condensed Consolidating Statement of Operations for the nine month period ended July 28, 2006.

(In thousands)

 

      Parent     Guarantor
Subsidiaries
    Non-
Guarantor
Subsidiaries
    Eliminations     Total  

Net Sales

   $          —     $  461,969     $    251,503     $    (11,470 )   $   702,002  

Cost of Sales

       314,830     179,687     (11,470 )   483,047  
   
       147,139     71,816         218,955  

Expenses

          

Selling, general
and administrative

       73,026     45,397         118,423  

Research, development
and engineering

       16,169     21,583         37,752  
   

Total Expenses

       89,195     66,980         156,175  

Other

          

Other (income) expense

       (873 )   428         (445 )
   

Total Other

       (873 )   428         (445 )
   

Operating Earnings

       58,817     4,408         63,225  

Interest income

   (15,925 )   (3,547 )   (1,268 )   18,490     (2,250 )

Interest expense

   15,362     10,326     8,683     (18,490 )   15,881  

Loss on extinguishment of debt

   2,156                 2,156  
   

Other Expense, Net

   1,593     6,779     7,415         15,787  
   

Income (Loss) Before
Income Taxes

   (1,593 )   52,038     (3,007 )       47,438  

Income Tax Expense (Benefit)

   (436 )   11,568     (1,693 )       9,439  
   

Income (Loss) Before
Minority Interest

   (1,157 )   40,470     (1,314 )       37,999  

Minority Interest

           (753 )       (753 )
   

Income (Loss)

   (1,157 )   40,470     (2,067 )       37,246  

Equity in Net Income of
Consolidated Subsidiaries

   38,403     3,479         (41,882 )    
   

Net Income (Loss)

   $    37,246     $    43,949     $    (2,067 )   $    (41,882 )   $    37,246  
   

 

29


Condensed Consolidating Statement of Cash Flows for the nine month period ended July 28, 2006.

(In thousands)

 

      Parent     Guarantor
Subsidiaries
    Non-
Guarantor
Subsidiaries
    Eliminations     Total  

Cash Flows Provided (Used)
by Operating Activities

          

Net earnings (loss)

   $    37,246     $    43,949     $    (2,067 )   $    (41,882 )   $    37,246  

Minority interest

           753         753  

Depreciation & amortization

       17,690     13,256         30,946  

Deferred income taxes

   1,403     (2,058 )   651         (4 )

Stock-based compensation

       2,773     1,453         4,226  

Gain on sale of short-term investments

   (610 )               (610 )

Working capital changes, net of effect of acquisitions

          

Accounts receivable

   (90 )   6,039     (483 )       5,466  

Inventories

       (21,778 )   (15,533 )       (37,311 )

Prepaid expenses

   4     709     (530 )       183  

Accounts payable

   8,674     (699 )   1,900         9,875  

Accrued liabilities

   (8,481 )   (2,089 )   (572 )       (11,142 )

Federal & foreign income taxes

   (856 )   (1,513 )   (9,012 )       (11,381 )

Other liabilities

   (2,256 )   (771 )   4,261         1,234  

Other, net

   5     (151 )   (471 )       (617 )
   
   35,039     42,101     (6,394 )   (41,882 )   28,864  

Cash Flows Provided (Used)
by Investing Activities

          

Purchases of capital assets

   (131 )   (11,485 )   (8,783 )       (20,399 )

Proceeds from sale of capital assets

   6     382     816         1,204  

Proceeds from sale of
short-term investments

   63,266                 63,266  

Acquisitions of businesses, net

       (3,519 )   (186,372 )       (189,891 )
   
   63,141     (14,622 )   (194,339 )       (145,820 )

 

30


(In thousands)

 

     Parent     Guarantor
Subsidiaries
    Non-
Guarantor
Subsidiaries
    Eliminations   Total  

Cash Flows Provided (Used)
by Financing Activities

         

Proceeds provided by stock
issuance under employee
stock plans

  3,851               3,851  

Excess tax benefits from
stock option exercises

  487               487  

Net change in credit facilities

          2,900       2,900  

Proceeds from issuance of
long-term debt

  100,000               100,000  

Repayment of long-term debt

  (70,000 )   1     (908 )     (70,907 )

Net change in intercompany
financing

  (197,767 )   (27,991 )   183,876     41,882    
   
  (163,429 )   (27,990 )   185,868     41,882   36,331  

Effect of Foreign Exchange
Rates on Cash

      (32 )   995       963  
   

Net Decrease in Cash
and Cash Equivalents

  (65,249 )   (543 )   (13,870 )     (79,662 )

Cash and Cash Equivalents
– Beginning of Period

  75,364     2,154     40,786       118,304  
   

Cash and Cash Equivalents
– End of Period

  $    10,115     $    1,611     $    26,916     $        —   $      38,642  
   

 

31


Item 2.        Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

We operate our businesses in three segments:   Avionics & Controls, Sensors & Systems and Advanced Materials. The Avionics & Controls segment designs and manufactures integrated cockpit systems, technology interface systems for military and commercial aircraft and land- and sea-based military vehicles, secure communications systems, specialized medical equipment, and other industrial applications. The Sensors & Systems segment produces high-precision temperature and pressure sensors, electrical power switching, control and data communication devices, micro-motors, motion control sensors, and other related systems, principally for aerospace and defense customers. The Advanced Materials segment develops and manufactures thermally engineered components and high-performance elastomer products used in a wide range of commercial aerospace and defense applications, combustible ordnance components and electronic warfare countermeasure devices for defense customers. Sales in all segments include domestic, international, defense and commercial customers.

Our current business and strategic plan focuses on the continued development of our products principally for aerospace and defense markets. We are concentrating our efforts to expand our capabilities in these markets and anticipate the global needs of our customers and respond to such needs with comprehensive solutions. These efforts focus on continuous research and new product development, acquisitions and establishing strategic realignments of operations to expand our capabilities as a more comprehensive supplier to our customers across our entire product offering. On March 14, 2007, we acquired CMC Electronics Holdings, Inc. (CMC) for approximately $344.3 million in cash, including acquisition costs and an adjustment based on the amount of cash and net working capital of CMC as of closing. CMC is a manufacturer of high technology avionics including global positioning systems, head-up displays, enhanced vision systems and electronic flight management systems. The acquisition significantly expands the scale of our existing Avionics & Controls business. CMC is included in the Avionics & Controls segment and the results of its operations were included from the effective date of the acquisition. We acquired Wallop Defence Systems Limited (Wallop) and FR Countermeasures on March 24, 2006 and December 23, 2005, respectively. Wallop and FR Countermeasures are manufacturers of military pyrotechnic countermeasure devices. We paid approximately $65.0 million for both companies, including acquisition costs and an adjustment based on the amount of indebtedness and net working capital as of closing. In addition, we may pay an additional purchase price of up to U.K. £10.0 million, or approximately $20.0 million, depending on the achievement of certain objectives. The acquisitions strengthen our international and U.S. position in countermeasure devices. Wallop and FR Countermeasures are included in our Advanced Materials segment. On December 16, 2005, we acquired Darchem Holdings Limited (Darchem), a manufacturer of thermally engineered components for critical aerospace applications for U.K. £68.7 million (approximately $121.7 million) including acquisition costs and an adjustment based on the amount of cash and net working capital of Darchem as of closing. Darchem holds a leading position in its niche market and fits our engineered-to-order model and is included in our Advanced Materials segment.

 

32


Net earnings for the nine month period ended July 27, 2007 were $71.4 million or $2.74 per diluted share, compared with $37.2 million or $1.44 per diluted share in the prior-year period, including a $26.1 million, net of tax or $1.00 per diluted share, insurance recovery. Avionics & Controls performance was strong compared to the prior-year period, offset by the effect of the shipment of acquired inventory of CMC which was required to be valued at fair value as of the date of acquisition. Results in Sensors & Systems improved and Advanced Materials earnings reflected strong sales and earnings as well as the insurance recovery referenced above. Interest expense increased $5.8 million, net of tax, over the prior-year period, reflecting the cost of financing the CMC acquisition. Net earnings for the nine month period ended July 27, 2007 reflected an effective tax rate of 23.1% (before a $2.6 million tax benefit) compared to 29.5% (before a $4.5 million reduction of previously estimated tax liabilities) for the prior-year period. For the nine month period ended July 28, 2006, non-operating expense included a $1.4 million, net of tax, make-whole payment arising from the $40.0 million prepayment of our 6.77% Senior Notes.

Results of Operations

Three Month Period Ended July 27, 2007 Compared to Three Month Period Ended July 28, 2006

Sales for the third fiscal quarter increased 31.4% compared with the prior-year period. Sales by segment were as follows:

(In thousands)

    

Incr./(Decr.)

from prior
  year period  

              Three Months Ended            
       July 27,
2007
   July 28,
2006

Avionics & Controls

   70.7%   $ 121,512    $ 71,191

Sensors & Systems

   15.1%     97,418      84,672

Advanced Materials

   16.1%     107,446      92,535
               

Total Net Sales

     $ 326,376    $ 248,398

The 70.7% increase in Avionics & Controls principally reflected incremental sales from the CMC acquisition. The increase also included higher sales volumes of cockpit controls and medical equipment devices from new OEM programs as well as strong after-market sales.

The 15.1% increase in sales of Sensors & Systems reflected higher temperature sensor sales and strong sales of electrical power switching devices from new OEM programs, as well as the effect of exchange rates. Sales in the third fiscal quarter of 2007 reflected a stronger U.K. pound and euro relative to the U.S. dollar, as the average exchange rate from the U.K. pound and euro to the U.S. dollar increased from 1.84 and 1.26, respectively, in the third fiscal quarter of 2006 to 2.00 and 1.35, respectively, in the third fiscal quarter of 2007.

The 16.1% increase in sales of Advanced Materials principally reflected increased demand from aerospace and defense customers across the segment.

 

33


Overall, for the third quarter of fiscal 2007, gross margin as a percentage of sales was 30.5% compared with 30.3% for the third quarter of fiscal 2006. Avionics & Controls segment gross margin was 30.9% and 34.7% for the third fiscal quarter of 2007 and 2006, respectively. The decrease in gross margin reflected the shipment of acquired inventory of CMC, which was valued at fair value at the date of acquisition. CMC’s gross margin in the third fiscal quarter of 2007 was also impacted by the effect of a weaker U.S. dollar compared to the Canadian dollar. Excluding CMC, Avionics & Controls gross margin was 38.1% and 34.7% for the third quarter of fiscal 2007 and 2006, respectively, reflecting increased after-market spares sales and pricing strength on certain cockpit control devices.

Sensors & Systems segment gross margin was 34.6% and 33.5% for the third fiscal quarter of 2007 and 2006, respectively. Gross margin reflected pricing strength in our electrical power switching devices, partially offset by the effect of a weaker U.S. dollar compared with the U.K. pound and euro on U.S. dollar-denominated sales and U.K. pound and euro-denominated cost of sales.

Advanced Materials segment gross margin was 26.4% and 24.1% for the third fiscal quarter of 2007 and 2006, respectively. Gross margin at Darchem as well as our combustible ordnance and elastomer operations increased over the third fiscal quarter of 2006 reflecting improved operational efficiencies and a higher recovery of fixed expenses due to higher sales. Gross margin was adversely impacted by the slow start-up of our FR Countermeasures unit in Tennessee.

Selling, general and administrative expenses (which include corporate expenses) totaled $55.5 million and $41.6 million for the third fiscal quarter of 2007 and 2006, respectively, or 17.0% of sales for the third fiscal quarter of 2007 compared with 16.7% for the third fiscal quarter of 2006. The increase in the amount of selling, general and administrative expenses primarily reflected incremental selling, general and administrative expenses from the CMC acquisition and higher corporate expenses. The increase in corporate expenses reflected bank fees associated with the modification of our 2013 indenture to permit non-U.S. subsidiaries to incur debt, severance costs, and increased incentive compensation. These increases were partially offset by a $1.6 million decrease in pension expense. In the third quarter of fiscal 2006, pension expense included a $1.1 million increase in the Leach pension obligation existing as of the acquisition of Leach in August 2004, which was identified during an audit of its pension plan.

Research, development and engineering spending was $17.0 million, or 5.2% of sales, for the third fiscal quarter of 2007 compared with $14.5 million, or 5.8% of sales, for the third fiscal quarter of 2006. The increase in research, development and engineering principally reflected spending on new programs, including the T6-B cockpit avionics system, A400M primary power distribution assembly, TP400 engine sensors, 787 overhead panel control and 787 environmental control programs. Research, development and engineering spending is expected to be about 5% of sales for the fourth quarter of fiscal 2007.

 

34


Segment earnings (operating earnings excluding corporate expenses and other income or expense) for the third fiscal quarter of 2007 totaled $69.4 million, compared with $26.2 million for the third fiscal quarter in 2006. Avionics & Controls segment earnings were $9.9 million for the third fiscal quarter of 2007 compared with $11.0 million for the third fiscal quarter of 2006, principally reflecting strong earnings from our cockpit control and medical equipment devices operations due to increased sales, substantially offset by the impact of the shipment of acquired inventory of CMC as described above.

Sensors & Systems segment earnings were $11.0 million for the third quarter of fiscal 2007 compared with $5.3 million for the third quarter of fiscal 2006. Sensors & Systems earnings principally reflected strong results from our electrical power switching devices operations and even results from our pressure and temperature operations. Comparing the third quarter of fiscal 2007 to the prior-year period, electrical power switching devices operations included a $1.1 million increase in the Leach pension obligation as explained above. Additionally, pressure and temperature operations earnings were impacted by a $1.0 million charge as a result of a customer contract termination in fiscal 2006.

Advanced Materials segment earnings were $48.5 million for the third fiscal quarter of 2007 compared with $9.9 million for the third fiscal quarter of 2006, principally reflecting $32.9 million in business interruption insurance recoveries as well as increased earnings from the Darchem acquisition and improved earnings from our elastomer and combustible ordnance operations. Earnings were impacted by start-up costs at our FR Countermeasures unit and low sales at our Wallop operations. The $32.9 million recovery is related to an explosion that occurred at Wallop on June 26, 2006, which resulted in one fatality and several minor injuries. Although the South facility is expected to be closed for about two years due to the requirements of the Health Safety Executive (HSE) to review the cause of the accident, normal operations are continuing at unaffected portions of the facility. The HSE investigation will not be completed until a Coroner’s Inquest is filed, possibly in 2008. Although it is not possible to determine the results of the HSE investigation or how the Coroner will rule, management does not expect to be found in breach of the Health & Safety Act related to the accident and, accordingly, no amounts have been recorded for any potential fines that may be assessed by the HSE. The HSE will also review and approve the plans and construction of the new flare facility. The $32.9 million insurance recovery is to reimburse the Company for the loss of earnings and damage to its South facility. We expect the South facility to be back in operation at the end of fiscal 2008.

Interest expense for the third fiscal quarter of 2007 was $10.8 million compared with $5.6 million for the third fiscal quarter of 2006, reflecting increased borrowings to finance the CMC acquisition.

The effective income tax rate for the third fiscal quarter of 2007 was 24.0% (before a $0.8 million tax benefit) compared with 29.8% (before a $1.6 million reduction of previously estimated tax liabilities) for the third fiscal quarter of 2006. The $0.8 million tax benefit was the result of a $1.4 million reduction in the U.K. subsidiaries’ deferred income taxes from the enactment of a tax law reducing the U.K. statutory corporate income tax rate from 30% to 28%, partially offset by a $0.6 million increase in previously estimated tax liabilities resulting from a

 

35


reconciliation of prior years’ income tax returns to the provision for income tax. The $1.6 million reduction of previously estimated tax liabilities was the result of the expiration of the statute of limitations and adjustments resulting from a reconciliation of the prior year’s U.S. income tax return to the provision for income taxes. The effective tax rate differed from the statutory rate in third fiscal quarters of 2007 and 2006 as both periods benefited from various tax credits and certain foreign interest expense deductions.

New orders for the third fiscal quarter of 2007 were $349.8 million compared with $250.6 million for the same period in 2006, reflecting incremental orders from the CMC acquisition, the timing of receiving orders and the underlying strength of the business across all segments.

Nine Month Period Ended July 27, 2007 Compared to Nine Month Period Ended July 28, 2006

Year-to-date sales increased 27.6% compared with the prior-year period. Sales by segment were as follows:

(In thousands)

    

Incr./(Decr.)

from prior
  year period  

              Nine Months Ended            
       July 27,
2007
   July 28,
2006

Avionics & Controls

   48.6%   $ 305,331    $ 205,497

Sensors & Systems

   16.7%     281,732      241,319

Advanced Materials

   21.0%     308,837      255,186
               

Total Net Sales

     $ 895,900    $ 702,002
               

The 48.6% increase in Avionics & Controls was principally due to incremental sales from the CMC acquisition and higher sales volumes of cockpit controls and medical equipment devices from new OEM programs and after-market demand.

The 16.7% increase in sales of Sensors & Systems reflected higher temperature sensor after-market sales and strong sales of electrical power switching devices from new OEM programs, as well as the effect of exchange rates. Sales in the first nine months of fiscal 2007 reflected a stronger U.K. pound and euro relative to the U.S. dollar, as the average exchange rate from the U.K. pound and euro to the U.S. dollar increased from 1.78 and 1.22, respectively, in the first nine months of fiscal 2006 to 1.97 and 1.33, respectively, in the first nine months of fiscal of 2007.

The 21.0% increase in sales of Advanced Materials reflected strong sales across the segment.

Overall, gross margin as a percentage of sales was 30.5% and 31.2% for the first nine months of fiscal 2007 and 2006, respectively. Avionics & Controls segment gross margin was 32.2% and 35.2% for the first nine months of fiscal 2007 and 2006, respectively, reflecting the shipment of acquired inventory of CMC, which was valued at fair value at the date of acquisition. In addition, CMC’s gross margins were impacted by the effect of a weaker U.S. dollar compared

 

36


with the Canadian dollar on U.S. dollar-denominated sales and Canadian denominated cost of sales. Excluding CMC, Avionics & Controls gross margin was 36.2% and 35.2% for the first nine months of fiscal 2007 and 2006, respectively, reflecting increased after-market spares sales and pricing strength on certain cockpit control devices.

Sensors & Systems segment gross margin was 33.1% and 33.3% for the first nine months of fiscal 2007 and 2006, respectively. Gross margin in the first nine months of fiscal 2007 was impacted by a contract overrun at a small unit which manufactures precision gears and data concentrators. In addition, gross margins were impacted by the effect of a weaker U.S. dollar compared with the U.K. pound and euro on U.S. dollar-denominated sales and U.K. pound and euro-denominated cost of sales. Pricing strength favorably affected gross margin at our U.S. manufacturer of electrical power switching devices. In addition, in the prior-year period, Sensors & Systems absorbed the impact of the move of our sensor indicator operation to a new facility and incurred excess cost of sales due to the production ramp up on the industrial sensors for a relatively new program.

Advanced Materials segment gross margin was 26.4% and 26.0% for the first nine months of fiscal 2007 and 2006, respectively. The increase in Advanced Materials gross margin was due to strong gross margins at our U.S. flare operations resulting from a more favorable mix of product shipments and improved operating efficiencies at our Arkansas countermeasure flare operation. Additionally, gross margins at our elastomer operations reflected an increased mix of higher margin aerospace sales and an improved recovery of fixed expenses due to higher sales. Comparing the first nine months of fiscal 2007 to 2006, the increase in gross margin also reflected the impact at Darchem of the shipment of acquired inventories, which were valued at fair market at acquisition. Gross margins in the first nine months of fiscal 2007 were impacted by the continued shut-down of our advanced flares operation at Wallop as a result of the explosion, explained above, and start-up costs at our FR Countermeasures unit acquired in December 2005.

Selling, general and administrative expenses (which include corporate expenses) totaled $148.2 million and $118.4 million for the first nine months of fiscal 2007 and 2006, respectively, or 16.5% of sales, for the first nine months of fiscal 2007 compared with 16.9% for the prior-year period. The increase in the amount of selling, general and administrative expenses primarily reflected incremental selling, general and administrative expenses from the CMC, Wallop, FR Countermeasures and Darchem acquisitions. The increase in corporate expense principally reflected bank fees associated with the modification of our 2013 indenture to permit non-U.S. subsidiaries to incur debt, severance costs, increased incentive compensation, an adjustment to rent expense, and the cost of an option to buy Canadian dollars to cover a portion of the purchase price of CMC. These increases were partially offset by a $2.3 million decrease in pension expense. In the third quarter of fiscal 2006, pension expense included a $1.1 million increase in the Leach pension obligation existing as of the acquisition of Leach in August 2004, which was identified during an audit of its pension plan.

Research, development and engineering expenses were $49.6 million, or 5.5% of sales for the first nine months of fiscal 2007 compared with $37.8 million, or 5.4% of sales, for the first nine

 

37


months of fiscal 2006. The increase in research, development and engineering principally reflected spending on new programs, including the T6-B, A400M primary power distribution assembly, TP400 engine sensors, 787 overhead panel control and 787 environmental control programs. Research, development and engineering spending is expected to be about 5% of sales for the fourth quarter of fiscal 2007.

Segment earnings (operating earnings excluding corporate expenses and other income or expense) for the first nine months of fiscal 2007 totaled $138.7 million, compared with $83.8 million for the prior-year period. Avionics & Controls segment earnings were $33.2 million for the first nine months of fiscal 2007 compared with $31.7 million in the prior-year period, principally reflecting strong earnings from our cockpit control and medical equipment devices operation, partially offset by the shipment of acquired inventory of CMC, which was valued at fair value at acquisition. CMC’s earnings were impacted by the effect of a weaker U.S. dollar compared with the Canadian dollar on U.S. dollar-denominated sales and Canadian-denominated cost of sales. Since the acquisition of CMC, the U.S. dollar has declined 10.7% against the Canadian dollar.

Sensors & Systems segment earnings were $25.0 million for the first nine months of fiscal 2007 compared with $18.4 million in the prior-year period. Operating earnings at our electrical power switching devices operation reflected improved results from increased sales from new OEM programs, a reimbursement of research, development and engineering expense negotiated with a customer and price increases, which were partially offset by higher research, development and engineering expenses on the A400M program. The improved results at our pressure and temperature sensors operations reflected higher after-market sales and an increased government subsidy for research and development expenses. Comparing results to the prior-year period, the first nine months of fiscal 2006 included a $1.0 million charge due to a customer contract termination and a $1.1 million increase in the Leach pension obligation as explained above.

Advanced Materials segment earnings were $80.5 million for the first nine months of fiscal 2007 compared with $33.7 million for the prior-year period, principally reflecting $37.3 million in business interruption insurance recoveries, incremental earnings from the Darchem acquisition and improved earnings from our elastomer and Arkansas countermeasure flare operations. Earnings in both years were impacted by start-up costs at our FR Countermeasures unit and low sales at our Wallop operations.

Interest expense for the first nine months of fiscal 2007 was $25.0 million compared with $15.9 million for the prior-year period, reflecting increased borrowings to finance the CMC acquisition.

The effective income tax rate for the first nine months of fiscal 2007 was 23.1% (before a $2.6 million tax benefit), compared with 29.5% (before a $4.5 million reduction of previously estimated tax liabilities) for the first nine months of fiscal 2006. The $2.6 million tax benefit in the first nine months of 2007 was the result of the following: 1) a $1.8 million benefit from the retroactive extension of the U.S. Research and Experimentation tax credit that was signed into law on December 21, 2006; 2) a $1.4 million reduction in U.K. subsidiaries’ deferred income

 

38


taxes resulting from the enactment of a tax law reducing U.K. statutory corporate income tax from 30% to 28%; and 3) a $0.6 million increase of previously estimated tax liabilities due to a reconciliation of prior years’ income tax return to the provision for income tax. The change in the effective tax rate for the first nine months of fiscal 2007 compared to the prior-year period reflects the incremental financing costs attributable to CMC’s acquisition in income before income taxes and the effect of including CMC’s tax credits and other tax efficiencies. In addition, for the first nine months of fiscal 2007, the effective tax rate was favorably impacted by the extension of the U.S. Research and Experimentation tax credit through December 31, 2007. In the first nine months of fiscal 2006, the $4.5 million reduction of previously estimated tax liabilities was the result of a $1.6 million reduction of previously estimated tax liabilities due to the expiration of the statute of limitations and adjustments resulting from a reconciliation of the prior year’s income tax return to the provision for income tax and $2.9 million for favorable settlements of tax audits. The effective tax rate differed from the statutory rate in the first nine months of 2007 and 2006, as both years benefited from various tax credits and certain foreign interest expense deductions.

New orders for the first nine months of fiscal 2007 were $1,220.3 million compared with $854.8 million for the same period in fiscal 2006, including backlog acquired from CMC. Backlog at July 27, 2007, was $977.9 million compared with $635.6 million at July 28, 2006. Approximately $450.4 million in backlog is scheduled for delivery after fiscal 2007. Most orders in backlog are subject to cancellation until delivery.

Liquidity and Capital Resources

Cash and cash equivalents at July 27, 2007 totaled $83.7 million, an increase of $41.0 million from October 27, 2006. Net working capital increased to $330.1 million at July 27, 2007 from $267.7 million at October 27, 2006. Sources of cash flows from operating activities principally consist of cash received from the sale of products offset by cash payments for material, labor and operating expenses. Cash flows from operating activities were $110.8 million and $28.9 million in the first nine months of fiscal 2007 and 2006, respectively. The increase principally reflected higher net earnings, which included cash received from our insurance carrier, increased cash received from the sale of our products, decreased purchases of inventory and lower payments of income taxes. These increases were partially offset by an increased pension contribution to our U.S. pension plan maintained by Leach in the first quarter of 2007.

Cash flows used by investing activities were $365.4 million and $145.8 million in the first nine months of fiscal 2007 and 2006, respectively. The increase in cash used for investing activities mainly reflected cash paid for acquisitions of businesses, partially offset by the proceeds from the sale of short-term investments in the prior-year period.

Cash flows provided by financing activities were $293.5 million and $36.3 million in the first nine months of fiscal 2007 and 2006, respectively. The increase in cash provided by financing activities reflected the issuance of $175.0 million Senior Notes due in 2017 and a $17.4 million net increase in credit facilities, offset by the repayment of our $30.0 million 6.4% Senior Notes in accordance with terms and the $40.0 million prepayment of our 6.77% Senior Notes in the first fiscal quarter of 2006.

 

39


Capital expenditures, consisting of machinery, equipment and computers, are anticipated to be approximately $33.0 million during fiscal 2007, compared with $26.5 million expended in fiscal 2006. Capital expenditures for the first nine months of fiscal 2007 totaled $24.3 million, primarily for machinery and equipment and enhancements to information systems.

Total debt at July 27, 2007 was $594.3 million and consisted of $175.0 million of Senior Notes due in 2017, $173.4 million of Senior Subordinated Notes due in 2013, $112.6 million under our GBP Term Loan, $100.0 million under our U.S. term loan facility, and $33.3 million of various foreign currency debt agreements and other debt agreements, including capital lease obligations. The Senior Notes are due March 1, 2017 and bear an interest rate of 6.625%. The Senior Subordinated Notes are due June 15, 2013 and bear an interest rate of 7.75%. In September 2003, we entered into an interest rate swap agreement on $75.0 million of our Senior Subordinated Notes due in 2013. The swap agreement exchanged the fixed rate for a variable interest rate on $75.0 million of the $175.0 million principal amount outstanding. On November 15, 2005, the $30.0 million 6.4% Senior Notes matured and were paid. Additionally, on November 15, 2005, we prepaid the outstanding principal amount of $40.0 million of our 6.77% Senior Notes due November 15, 2008. Under the terms of the Note Purchase Agreement, we paid an additional $2.2 million make-whole payment, which was recorded as a loss on extinguishment of debt in the first quarter of fiscal 2006. On February 10, 2006, we amended our credit agreement to provide a $100.0 million term loan facility, which may be drawn in U.S. dollars, U.K. pounds or euros. On February 10, 2006 we borrowed U.K. £57.0 million, or approximately $100.0 million, under the term loan facility. We used the proceeds from the loan as working capital for our U.K. operations and to repay a portion of our outstanding borrowings under our revolving credit facility. The principal amount of the loan is payable quarterly commencing on March 31, 2007 through the termination date of November 14, 2010 according to a payment schedule by which 1.25% of the principal amount is paid in each quarter of 2007, 2.50% in each quarter of 2008, 5.00% in each quarter of 2009 and 16.25% in each quarter of 2010. The loan accrues interest at a variable rate based on the British Bankers Association Interest Settlement Rate for deposits in U.K. pounds plus an additional margin amount that ranges from 1.13% to 0.50% depending upon our leverage ratio. At July 27, 2007, the interest rate on the term loan was 6.81%. We also entered into an interest rate swap agreement on the full principal amount of the term loan, exchanging the variable interest rate for a fixed interest rate of 4.75% plus an additional margin amount determined by reference to the Company’s leverage ratio. In addition, in November 2005, we collateralized a $9.9 million letter of credit with an equivalent amount of cash and cash equivalents.

On March 14, 2007, we acquired CMC Electronics Holdings Inc. (CMC) for approximately $344.3 million in cash, including acquisition costs. The acquisition was financed in part with the proceeds of the $175 million Senior Notes due March 1, 2017. In addition, on March 13, 2007, the Company amended its credit agreement to increase the existing revolving credit facility to $200.0 million and to provide an additional $100.0 million U.S. term loan facility. On March 13, 2007 the Company borrowed $60.0 million under the revolving credit facility and

 

40


$100.0 million under the U.S. term loan facility to pay a portion of the purchase price of the acquisition of CMC; the Company repaid $35.0 million through July 27, 2007.

We believe cash on hand and funds generated from operations are adequate to service operating cash requirements and capital expenditures through July 2008. In addition, we believe that we have adequate access to capital markets to fund future acquisitions.

Forward-Looking Statements

This quarterly report on Form 10-Q contains forward-looking statements. These statements relate to future events or our future financial performance. In some cases you can identify forward-looking statements by terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “should” or “will” or the negative of such terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risk factors set forth in “Forward-Looking Statements and Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended October 27, 2006, that may cause our or the industry’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. You should not place undue reliance on these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, performance or achievements. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included or incorporated by reference into this report are made only as of the date hereof. We do not undertake and specifically decline any obligation to update any such statements or to publicly announce the results of any revisions to any such statements to reflect future events or developments.

Item 4.          Controls and Procedures

Our principal executive and financial officers evaluated our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of July 27, 2007. Based upon that evaluation, they concluded as of July 27, 2007 that our disclosure controls and procedures were effective to ensure that information we are required to disclose in the reports that we file under the Exchange Act is recorded, processed, summarized and reported within time periods specified in Securities and Exchange Commission rules and forms. In addition, our principal executive and financial officers concluded as of July 27, 2007 that our disclosure controls and procedures are also effective to ensure that information required to be disclosed in reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including to our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

During the time period covered by this report, there were no changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

41


PART II – OTHER INFORMATION

Item 1.         Legal Proceedings

From time to time we are involved in legal proceedings arising in the ordinary course of business. We believe that adequate reserves for these liabilities have been made and that there is no litigation pending that could have a material adverse effect on our results of operations and financial condition.

 

42


Item 6.         Exhibits

 

   4.1    Supplemental Indenture, dated as of June 27, 2007, among Esterline Technologies Corporation, the Subsidiary Guarantors set forth on the signature pages to the Indenture and The Bank of New York Trust Company, N.A. (Incorporated herein by reference to Exhibit 4.1 to Esterline Technologies Corporation’s Current Report on Form 8-K dated June 28, 2007 [Commission File No. 1-6357].)
   4.2    Supplemental Indenture, dated as of July 26, 2007, among Esterline Technologies Corporation, the Subsidiary Guarantors set forth on the signature pages to the Indenture and Wells Fargo Bank, N.A. (Incorporated herein by reference to Exhibit 4.4 to Esterline Technologies Corporation’s Amendment No. 1 to Registration Statement on Form S-4 filed August 6, 2007 [Commission File No. 333-144161].)
   4.3    Amendment to 2007 Registration Rights Agreement, dated July 31, 2007, among Esterline Technologies Corporation, the Guarantors set forth on the signature pages to the Registration Rights Agreement and the Initial Purchasers. (Incorporated herein by reference to Exhibit 4.4 to Esterline Technologies Corporation’s Amendment No. 1 to Registration Statement on Form S-4 filed August 6, 2007 [Commission File No. 333-144161].)
   11    Schedule setting forth computation of basic and diluted earnings per common share for the three and nine month periods ended July 27, 2007 and July 28, 2006.
   31.1    Certification of Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   31.2    Certification of Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   32.1    Certification (of Robert W. Cremin) pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   32.2    Certification (of Robert D. George) pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

43


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ESTERLINE TECHNOLOGIES CORPORATION
                                  (Registrant)
Dated:  August 31, 2007   By:  

/s/ Robert D. George

    Robert D. George
    Vice President, Chief Financial Officer,
   

Secretary and Treasurer

(Principal Financial Officer)